Ravi Sun

Dr. Ravi Sun

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2017 in Journal of Biophotonics
Verified
Journal Article
Closed access
PDF file
RSRavi Sun
Ravi Sun
Valery TuchinValery Tuchin
Valery Tuchin
VZVladimir P. Zharov
Vladimir P. Zharov
EGEkaterina Galanzha
Ekaterina Galanzha
GRGresham Thomas Richter
Gresham Thomas Richter

27 May 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMichael J. Schonning
Michael J. Schonning
SKSeung Koh
Seung Koh
RSRavi Sun
Ravi Sun
GRGresham T. Richter
Gresham T. Richter
AEAndrew K. Edwards
Andrew K. Edwards
June K. WuJune K. Wu
June K. Wu
Venous malformations (VMs) are slow-flow malformations of the venous vasculature and are the most common type of vascular malformation with a prevalence of 1%. Germline and somatic mutations have been shown to contribute to VM pathogenesis, but how these mutations affect VM pathobiology is not well understood. The goal of this study was to characterize VM endothelial and mural cell expression by performing a comprehensive expression analysis of VM vasculature. VM specimens (n = 16) were stained for pan-endothelial, arterial, venous, and endothelial progenitor cell proteins; proliferation was assessed with KI67. Endothelial cells in the VM vessels were abnormally orientated and improperly specified, as seen by the misexpression of both arterial and endothelial cell progenitor proteins not observed in control vessels. Consistent with arterialization of the endothelial cells, VM vessels were often surrounded by multiple layers of disorganized mural cells. VM endothelium also had a significant increase in proliferative endothelial cells, which may contribute to the dilated channels seen in VMs. Together the expression analysis indicates that the VM endothelium is misspecified and hyperproliferative, suggesting that VMs are biologically active lesions, consistent with clinical observations of VM progression over time.

22 April 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
RSRavi Sun
Ravi Sun
HHaihong Zhang
Haihong Zhang
Syed MehdiSyed Mehdi
Syed Mehdi
GRGresham Thomas Richter
Gresham Thomas Richter
HBHayden H. Bowman
Hayden H. Bowman
GSGraham Michael Strub
Graham Michael Strub

2 September 2017 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
RSRavi Sun
Ravi Sun
JBJuliana Bonilla‐Velez
Juliana Bonilla‐Velez
RPRobert D. Pesek
Robert D. Pesek
AJAdam B. Johnson
Adam B. Johnson
MCMario A. Cleves
Mario A. Cleves
GRGresham Thomas Richter
Gresham Thomas Richter

16 December 2025 in The FASEB Journal
Verified
Journal Article
Open access
RSRavi Sun
Ravi Sun
HZHaihong Zhang
Haihong Zhang
SMSyed J. Mehdi
Syed J. Mehdi
JBJordan K. Bowen
Jordan K. Bowen
ABAlexander K. Burnett
Alexander K. Burnett
GSGraham Michael Strub
Graham Michael Strub
Cystic lymphatic malformations (LMs) are congenital anomalies characterized by the formation of dilated lymphatic channels that can infiltrate adjacent structures and cause significant morbidity. Somatic activating single nucleotide variants in PIK3CA have been identified in the majority of these lesions, yet the precise mechanisms underlying the role of these variants in LM progression remain unclear. Here, we investigated the role of Angiopoietin‐2 (Ang2) downregulation downstream of pathogenic PIK3CA variants in the pathogenesis of LMs and delineated a novel inhibitory mechanism for autocrine Ang2 in the lymphatic vasculature. Transcriptomic profiling of patient‐derived LM endothelial cells (LMECs) with PIK3CA variants revealed Ang2 as one of the most significantly downregulated genes. Overexpression of ANG2 in LMECs and normal human dermal lymphatic endothelial cells significantly suppressed their proliferation and inhibited VEGFR3 expression. In contrast, non‐cell autonomous derived or exogenous ANG2 significantly promoted LMEC viability and increased AKT activity. Treatment of LMECs with the PI3K inhibitor alpelisib, but not the mTOR inhibitor sirolimus (rapamycin), rescued autocrine ANG2 expression and significantly downregulated VEGFR3. Alpelisib or sirolimus in combination with ANG2 overexpression significantly reduced LMEC viability compared to ANG2 overexpression or drug treatment alone. Finally, ANG2 overexpression in LMECs suppressed the LM phenotype in a murine xenograft model. Together, our findings suggest that targeting autocrine Ang2 signaling may be a viable option for suppressing pathological lymphangiogenesis.

6 March 2022 in Clinical Case Reports
Verified
Journal Article
Open access
AYAddison Yee
Addison Yee
SNSriram Navuluri
Sriram Navuluri
RSRavi Sun
Ravi Sun
MLMiki Lindsey
Miki Lindsey
LGLaura A Gonzalez‐Krellwitz
Laura A Gonzalez‐Krellwitz
GSGraham Michael Strub
Graham Michael Strub
Bronchogenic cysts are embryologic malformations of the foregut and are rarely found head and neck region. Here we present a case of an upper scapular/lower posterior neck cystic mass which was initially suspicious for lymphatic malformation but confirmed by pathology to be an ectopic bronchogenic cyst.